Home › NDC Lookup › Ingredients › Quetiapine › 16729-0149-01
⚪image loading
(from DailyMed)

Quetiapine 300 mg Tablet, Film Coated, 100-count — NDC 16729-149-01 (Billing 16729-0149-01)

by Accord Healthcare Inc. · 100 TABLET, FILM COATED in 1 BOTTLE

This is a package of 100 tablets of Quetiapine 300 mg Tablet, Film Coated from Accord Healthcare Inc., marketed since Dec 2015 and currently FDA-listed; retail pharmacies pay about $0.1904 per tablet (NADAC).

NDC 16729-0149-01
🏷️ FDA NDC (as labeled) 16729-149-01 billing pads the product segment with a zero
This package
Contains100-count Cost per ea$0.1904 NADAC Per package$19.04 / 100 tablets Pack sizes5 compare ↓
Also priced by: Part D plans $0.1085/unit — full pricing hub ↓
Product page 16729-0149-12 Also comes in: 30 tablets 16729-149-10 60 tablets 16729-149-12 1000 tablets 16729-149-17 2000 tablets 16729-149-18
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 16729-149-01 alone.

Record
FDA NDC Directory package listing · Drug for further processing
Code segments
16729 labeler · 149 product · 01 package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 1672914901 3
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 16729-149-01
Product NDC 16729-149
11-digit billing NDC 16729014901
NCPDP billing unit EA — each (per item)
SPL Set ID ecb554a8-93c9-5a7f-e053-2995a90ac83d
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2015-12-16
Dosage form TABLET, FILM COATED
Substance QUETIAPINE FUMARATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 59153070100340
GPI class QUEtiapine Fumarate
GCN Seq No 047198
GCN 67665
HICL code 014015
Ingredient (HICL) Quetiapine Fumarate
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H7
Therapeutic class — intermediate (HIC2) Psychoactive Drugs (Continued 1)
HIC3 code H7T
Therapeutic class — specific (HIC3) Antipsychotic,Atypical,Dopamine,Serotonin Antagnst
AHFS code 28:16.08.04
AHFS class Atypical Antipsychotics
FDB label name QUETIAPINE FUMARATE 300 MG TAB
FDB brand name Quetiapine Fumarate
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 047198
  • GCN: 67665
  • GPI-14 (Medi-Span): 59153070100340
  • HICL (First Databank): 014015
  • AHFS class code: 28:16.08.04
Why two NDCs? The FDA registers this code as 16729-149-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 16729-0149-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name QUETIAPINE FUMARATE 300 MG TAB Ingredient Quetiapine Fumarate
📗 Our plain-language guide HelloPharmacist
  • It treats schizophrenia and bipolar disorder, including manic and depressive episodes. Extended-release versions can also be added to an antidepressant for major depressive disorde...
  • Regular tablets can be taken with or without food. Extended-release tablets are taken once daily, usually in the evening, without food or with a light meal, and must be swallowed w...
  • Sleepiness, dry mouth, dizziness, constipation, increased appetite and weight gain are the most common. Many people notice these early on. Tell your doctor if they bother you.
  • Call right away for suicidal thoughts, worsening mood, fever with stiff muscles and confusion, uncontrolled movements, fainting, seizures, signs of infection, or high blood sugar s...
📖 Read our full Quetiapine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.190 $19.04 / 100 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.1085 $10.85 / 100 tablets
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Apr 2022 Sep 2022 Feb 2024 $0.190 $0.134
▲ Up 27% over the last 15 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
16729-0149-01 You're viewing this 100 TABLET, FILM COATED in 1 BOTTLE $0.1904 / ea $19.04 2015-11-02 — Active
16729-0149-10 16729-149-10 30 TABLET, FILM COATED in 1 BOTTLE — — 2012-03-28 — Active
16729-0149-12 16729-149-12 Main listing 60 TABLET, FILM COATED in 1 BOTTLE $0.1465 / ea $8.79 2012-03-28 — Active
16729-0149-17 16729-149-17 1000 TABLET, FILM COATED in 1 BOTTLE $0.1904 / ea $190.42 2012-03-28 — Active
16729-0149-18 16729-149-18 2000 TABLET, FILM COATED in 1 CONTAINER — — — — Active

You're viewing one of 5 pack sizes for this product.

Per ea, this pack runs about 30% above the cheapest pack (60-count, $0.1465 vs $0.1904 NADAC).

This pack shows little to no recent Medicaid volume — the 60 tablets pack carries most fills. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet, film coated in 1 bottle.
How does this package differ from NDC 16729-0149-10?
Both are Quetiapine 300 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 100-count one, while NDC 16729-0149-10 is the 30 tablets package.
What NDC number is used to bill for this package of Quetiapine 300 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Quetiapine 300 mg 00093-8164-01 Teva 100 tablets $0.127 AB Discontinued save 33%
Quetiapine 300 mg 00904-6642-61 Major 100 tablets $0.127 AB Availability likely save 33%
Quetiapine Fumarate 300 mg 16571-0721-01 Rising 100 tablets $0.127 AB Availability likely save 33%
Quetiapine Fumarate 300 mg 16714-0379-01 NorthStar 100 tablets $0.127 AB Discontinued save 33%
Quetiapine Fumarate 300 mg 29300-0151-01 Unichem 100 tablets $0.127 AB Availability likely save 33%
Quetiapine Fumarate 300 mg 31722-0768-01 Camber 60 tablets $0.127 AB Availability likely save 33%
Quetiapine 300 mg 43547-0522-06 Solco 60 tablets $0.127 AB Availability likely save 33%
Quetiapine Fumarate 300 mg 50268-0634-15 AvPAK 50 tablets $0.127 AB Availability likely save 33%
Quetiapine fumarate 300 mg 60687-0371-01 American 100 tablets $0.127 AB Availability likely save 33%
Quetiapine 300 mg 67877-0247-10 Ascend 1000 tablets $0.127 AB Availability likely save 33%
Quetiapine fumarate 300 mg 68001-0183-00 BluePoint 100 tablets $0.127 AB Availability likely save 33%
Quetiapine fumarate 300 mg 68180-0449-01 Lupin 100 tablets $0.127 AB Availability likely save 33%
Quetiapine fumarate 300 mg 47335-0906-18 Sun 1000 tablets $0.129 AB Discontinued save 33%
Quetiapine 300 mgthis 16729-0149-01 Accord 100 tablets $0.190 — FDA listed —
Quetiapine fumarate 300 mg 33342-0104-09 Macleods 60 tablets $0.190 AB FDA listed —
Seroquel 300 mg 00310-0274-60 AstraZeneca 60 tablets $15.909 AB Availability likely +8255%
Quetiapine Fumarate 300 mg 00054-0223-20 Hikma 100 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 00615-8474-39 NCS 30 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 46708-0138-10 Alembic 100 tablets — — FDA listed —
Quetiapine Fumarate 300 mg 50090-3983-00 A-S 60 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 51407-0070-05 Golden 500 tablets — AB FDA listed —
Seroquel 300 mg 61269-0254-60 H2-Pharma, 60 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 65862-0494-01 Aurobindo 100 tablets — AB FDA listed —
Quetiapine fumarate 300 mg 67046-0638-03 Coupler 30 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 68071-1669-06 NuCare 60 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 68071-3599-06 NuCare 60 tablets — AB FDA listed —
Quetiapine fumarate 300 mg 68071-3940-06 NuCare 60 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 68788-8530-03 Preferred 30 tablets — AB FDA listed —
Quetiapine fumarate 300 mg 70518-1919-01 REMEDYREPACK 30 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 70518-3609-00 REMEDYREPACK 30 tablets — AB FDA listed —
Quetiapine 300 mg 70518-4451-00 REMEDYREPACK 30 tablets — AB FDA listed —
Quetiapine 300 mg 71205-0026-03 Proficient 3 tablets — AB FDA listed —
Quetiapine fumarate 300 mg 71335-0772-01 Bryant 30 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 71335-1709-01 Bryant 30 tablets — AB FDA listed —
Quetiapine fumarate 300 mg 71335-2278-01 Bryant 30 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 71335-9697-01 Bryant 30 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 71610-0127-18 Aphena 3000 tablets — AB FDA listed —
Quetiapine Fumarate 300 mg 72865-0268-01 XLCare 100 tablets — AB FDA listed —
Quetiapine 300 mg 76420-0519-01 ASCLEMED 10 tablets — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2015
On the market since
Dec 2015
📍
2026
Currently FDA-listed
11 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Quetiapine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAccord Healthcare Inc.
Labeler code16729
First marketedDec 2015
Product typeDrug For Further Processing
Portfolio143 products on file

More NDCs from Accord Healthcare Inc. labeler code 16729

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
60 tablets16729-0149-12 718 Rx · $10,238
1000 tablets16729-0149-17 15 Rx · $234
100 tablets this page16729-0149-01 No Medicaid data
30 tablets16729-0149-10 No Medicaid data
2000 tablets16729-0149-18 No Medicaid data
Drug total (last 4 qtrs): 733 Rx · 26,456 units · $10,473 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Accord Healthcare Inc. supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Accord Healthcare Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 30 tablets (16729-0149-10), 60 tablets (16729-0149-12), 1000 tablets (16729-0149-17). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Accord Healthcare Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 16729-0148-01 · Accord 16729-0150-01 · Accord →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.